Previous studies have proven that tumor multifocality in PTC patients is no longer drastically related to TERT promoter mutations (pooled OR = 0.67, 95%CI = 0.14–3.24, p < 0.62) (Figure 5). This evidence concerns the gene TERT and neoplasm.